China Universal Asset Management »

Inozyme Pharma shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $12k 13k 0.91
2024-12-31 $38k 14k 2.77

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Inc-cl A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Alphabet Inc-cl C Common Stock (GOOG)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Proshares Ultra Gold Etp (UGL)
Netflix Common Stock (NFLX)
Spdr Gold Minishares Trust Etp (GLDM)

View all positions for China Universal Asset Management